Entries by drdeannaattai

, , , , , , , ,

Updates from #ASBrS19

6 March 2019 The American Society of Breast Surgeons (ASBrS) held their annual meeting in Dallas last week. This meeting usually draws about 1500 breast surgeons (just under half the ASBrS membership) from around the world, for several days of pre-meeting courses, didactic sessions, and research presentations. In addition to the science, the meeting provides […]

, , ,

Updated Screening Mammography Statement from ASBrS

3 May 2019 The American Society of Breast Surgeons (ASBrS) has updated their screening mammography guideline, recommending that women of average risk begin annual screening mammograms at age 40. This update brings the ASBrS guideline more in line with those of the American College of Radiology and the Society of Breast Imaging, and are a […]

, , , , ,

Updates from #SSO2019

7 April 2019 The Society of Surgical Oncology held their annual meeting in San Diego, CA from March 27-30, 2019. Approximately 1700 surgical oncologists were in attendance. As the organization is geared towards the entire field of surgical oncology, only a portion of the meeting covered breast cancer. Here are some of the highlights: Genetic […]

,

Supplemental Breast Cancer Screening with Ultrasound

1 April 2019 A study recently published in JAMA Internal Medicine casts doubts on the commonly held belief that addition of screening ultrasound to screening mammography improves the rate of breast cancer detection.  It is well known that mammograms do not pick up all breast cancers. In the approximately 40% of women who undergo screening […]

,

Updates to the Mammography Quality Standards Act

30 March 2019 The US Food and Drug Administration (FDA) recently released a statement announcing amendments to the Mammography Quality Standards Act (MQSA). The “lay person letter” that patients receive with information about their mammogram results, and aspects of mammography facility quality measures, are part of the MQSA.  As noted in the FDA statement, proposed […]

,

Digital Breast Tomosynthesis

11 March 2019 A study recently published in JAMA Oncology adds to the growing body of literature noting the advantages of digital breast tomosynthesis (DBT), also known as 3D mammography, compared to the more widely available digital (2D) mammography (DM). While mammography is still considered the “gold standard” for breast cancer screening, there are some limitations. […]

FDA Advisory on Thermography

26 February 2019 The US Food and Drug Administration (FDA) has issued a safety communication regarding the use of breast thermography as a sole means of breast cancer screening or diagnosis. Thermography has been around for many years, and as seen by the FDA communication, has been the subject of multiple warning letters. Thermography works […]

,

PCP Involvement in Breast Cancer Decisions

19 February 2019  A study recently published in Cancer assessed primary care physician (PCP) knowledge about breast cancer treatment decisions, and their comfort level with having treatment option discussions with their patients.  PCPs were identified by their patients as part of a previous study. 61% of the 852 eligible PCPs responded to the survey request. […]

,

Updated Breast Cancer Genetic Testing Guidelines

12 February 2019 The American Society of Breast Surgeons has issued updated genetic testing guidelines for patients who have been diagnosed with breast cancer. The new guidelines recommend that genetic testing to include BRCA 1/2 and PALB2 mutations (and other genes as appropriate based on clinical scenario and family history) be made available to all newly […]